Filing Details
- Accession Number:
- 0001140361-10-010719
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-03-08 12:00:00
- Reporting Period:
- 2010-03-04
- Filing Date:
- 2010-03-08
- Accepted Time:
- 2010-03-08 20:42:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1221599 | Steve Aselage | C/O Biomarin Pharmaceutical Inc. 105 Digital Drive Novato CA 94949 | Evp, Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-03-08 | 24,090 | $7.16 | 55,361 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-03-04 | 5,000 | $21.50 | 50,361 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-03-05 | 6,416 | $21.95 | 43,945 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-03-08 | 24,090 | $22.11 | 19,855 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | $7.16 | 2006-07-01 | 2015-06-30 | 24,090 | 386,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2015-06-30 | 24,090 | 386,000 | Direct |
Footnotes
- The price in Column 4 is a weighted average price. The prices actually received ranged from $22.09 to $22.13. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- Original option grant vested 12/36ths on 7/1/06 and 1/36th on the 1st of every month thereafter.
Billionaire Hedge Funds
